Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 896.41 $ -10.30 (-1.14 %)    

Wednesday, 03-Jul-2024 12:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 490.95 $ 3.97 (0.82 %)
DIA $ 392.84 $ -0.45 (-0.11 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.25 (1.38 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 906.71
$ 910.25
$ 0.00 x 0
$ 896.94 x 200
$ 884.14 - $ 918.00
$ 431.12 - $ 916.83
4,584,602
na
819.48B
$ 0.57
$ 133.50
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

sp-500-nasdaq-100-climb-to-record-highs-as-data-fosters-rate-cut-optimism-ahead-of-fed-minutes-gold-bonds-rally-whats-driving-markets-wednesday
S&P 500, Nasdaq 100 Climb To Record Highs ...
07/03/2024 17:04:01

The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for...

eli-lillys-alzheimers-therapys-broad-label-reflects-regulatory-confidence-in-anti-amyloid-antibodies-analyst
Eli Lilly's Alzheimer's Therapy's Broad La...
07/03/2024 16:13:19

The FDA has approved Eli Lilly's Kisunla (donanemab) for early symptomatic Alzheimer's disease. Kisunla, targeting amyl...

Core News & Articles
Novo Nordisk Shares See Further Drop; 'Stu...
07/03/2024 15:31:06

https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study/A new observational study on Wednesday reported for ...

Core News & Articles
'Potential Link Between Ozempic, Wegovy An...
07/03/2024 15:03:44

https://nypost.com/2024/07/03/lifestyle/potential-link-between-ozempic-wegovy-and-serious-eye-condition-study/Researchers say t...

top-3-health-care-stocks-that-may-crash-this-quarter
Top 3 Health Care Stocks That May Crash Th...
07/03/2024 13:41:08

bmo-capital-maintains-outperform-on-eli-lilly-and-co-maintains-1001-price-target
BMO Capital Maintains Outperform on Eli Li...
07/03/2024 12:57:06

BMO Capital analyst Evan Seigerman maintains Eli Lilly and Co (NYSE:LLY) with a Outperform and maintains $1001 price target.

eli-lilly-shares-gain-after-drug-maker-gets-fdas-nod-for-early-alzheimers-treatment
Eli Lilly Shares Gain After Drug-Maker Get...
07/03/2024 08:20:41

The treatment is intended for adults in the early symptomatic stages of Alzheimer's disease.

tesla-paramount-global-annovis-bio-eli-lilly-amazon-why-these-5-stocks-are-on-investors-radars-today
Tesla, Paramount Global, Annovis Bio, Eli ...
07/03/2024 03:38:25

On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in p...

Core News & Articles
Benzinga Market Summary: Tesla Surges On D...
07/02/2024 20:01:23

lillys-alzheimers-drug-kisunla-to-cost-32k-for-first-year-12522-for-6-month-course-and-69565-per-vial
Lilly's Alzheimer's Drug Kisunla To Cost $...
07/02/2024 17:39:26

Core News & Articles
FDA Approves Kisunla For Early Symptomatic...
07/02/2024 17:36:24

joe-biden-suggests-novo-nordisk-eli-lilly-to-lower-prices-for-its-popular-obesity-drugs
Joe Biden Suggests Novo Nordisk, Eli Lilly...
07/02/2024 15:38:23

American leaders push for lower drug prices, highlighting recent legislation and widespread support for affordable medications....

fda-says-limited-availability-through-july-2024-of-mounjaro-injection-10-mg5-ml-limited-availability-through-july-2024-of-zepbound-injection-10-mg5-ml
FDA Says Limited Availability Through July...
07/02/2024 13:59:26

- Reuters

Core News & Articles
U.S. FDA Sends Warning Letter To Ozempen.c...
07/02/2024 13:24:01

- Reuters

Core News & Articles
Top 10 Trending Stocks On WallStreetBets A...
07/02/2024 13:16:27

TSLANVDAWAYAIAAPLAMDLOTAMZNLLYSMCIData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

Core News & Articles
'Biden Urges Novo Nordisk To Cut Ozempic A...
07/02/2024 11:58:34

https://www.usatoday.com/story/opinion/2024/07/02/biden-sanders-prescription-drug-cost-ozempic-wegovy/74232827007/

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
07/01/2024 17:35:22

sanofi-nears-decision-on-16b-upgrade-for-frankfurt-insulin-plant
Sanofi Nears Decision on $1.6B Upgrade For...
07/01/2024 15:13:28

Sanofi is set to invest up to $1.6 billion in its Frankfurt insulin production site, marking a significant win for Germany'...

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-and-co-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/01/2024 15:12:31

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.

radionetics-oncology-enters-strategic-agreement-with-lilly-receives-140m-upfront-payment-lilly-gains-exclusive-right-to-acquire-radionetics-for-1b-partnership-focuses-on-developing-gpcr-targeting-radiopharmaceuticals-for-solid-tumors-using-radionetics-proprietary-discovery-platform
Radionetics Oncology Enters Strategic Agre...
07/01/2024 14:04:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)